Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes

被引:39
|
作者
Erb, Steven M. [1 ]
Butrapet, Siritorn [2 ]
Moss, Kelley J. [2 ]
Luy, Betty E. [2 ]
Childers, Thomas [2 ]
Calvert, Amanda E. [2 ]
Silengo, Shawn J. [2 ]
Roehrig, John T. [2 ]
Huang, Claire Y. -H. [2 ]
Blair, Carol D. [1 ]
机构
[1] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA
[2] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA
关键词
Dengue virus; Flavivirus; Envelope protein; Domain III; FG loop; Mosquitoes; Mutagenesis; WEST-NILE-VIRUS; YELLOW-FEVER VIRUS; BORNE ENCEPHALITIS-VIRUS; CRYSTAL-STRUCTURE; RECEPTOR COMPLEX; E-GLYCOPROTEIN; PDK-53; VIRUS; FLAVIVIRUS; BINDING; ENTRY;
D O I
10.1016/j.virol.2010.07.024
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The FG extended loop in domain Ill of the dengue virus type 2 (DENV2) envelope protein is postulated to be a molecular determinant for host cell infectivity. To determine the contribution of the FG loop to virus infectivity, an infectious cDNA clone of DENV2 was manipulated by deleting amino acids in the loop (VEPG Delta) to mimic tick-borne flaviviruses or by substituting these AAs with RGD or RGDK/S to mimic motifs present in other mosquito-borne flaviviruses. We found the FG loop to be dispensable for infection of C6/36 cells but critical for infection of Aedes aegypti mosquito midguts and mammalian cells. All the FG loop mutants were able to bind to and enter mammalian cells but replication of VEPG Delta in Vero cells at 37 degrees C was delayed until acquisition of secondary mutations. Reduced binding of DENV2 type-specific monoclonal antibody 3H5 to mutant viruses confirmed the FG loop motif as its target epitope. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:328 / 335
页数:8
相关论文
共 42 条
  • [31] Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
    Gromowski, Gregory D.
    Barrett, Alan D. T.
    VIROLOGY, 2007, 366 (02) : 349 - 360
  • [32] Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies
    Batra, Gaurav
    Raut, Rajendra
    Dahiya, Satinder
    Kamran, Neha
    Swaminathan, Sathyamangalam
    Khanna, Navin
    JOURNAL OF VIROLOGICAL METHODS, 2010, 167 (01) : 10 - 16
  • [33] High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice
    Zhang, Zhi-Shan
    Yan, Yan-Sheng
    Weng, Yu-Wei
    Huang, Hai-Long
    Li, Shi-Qing
    He, Shi
    Zhang, Jian-Ming
    JOURNAL OF VIROLOGICAL METHODS, 2007, 143 (02) : 125 - 131
  • [34] Transgenic Expression of Human C-Type Lectin Protein CLEC18A Reduces Dengue Virus Type 2 Infectivity in Aedes aegypti
    Cheng, Lie
    Liu, Wei-Liang
    Tsou, Yun-Ting
    Li, Jian-Chiuan
    Chien, Chia-Hao
    Su, Matthew P.
    Liu, Kun-Lin
    Huang, Ya-Lang
    Wu, Shih-Cheng
    Tsai, Jih-Jin
    Hsieh, Shie-Liang
    Chen, Chun-Hong
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [35] Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice
    Arora, Upasana
    Tyagi, Poornima
    Swaminathan, Sathyamangalam
    Khanna, Navin
    VACCINE, 2013, 31 (06) : 873 - 878
  • [36] Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis
    Niu, Guoyu
    Pang, Zheng
    Guan, Chun
    Qi, Jun
    Li, Dexin
    VIRUS RESEARCH, 2015, 201 : 73 - 78
  • [37] Integrated process for the purification and immobilization of the envelope protein domain III of dengue virus type 2 expressed in Rachiplusia nu larvae and its potential application in a diagnostic assay
    Emilia Smith, Maria
    Marisa Targovnik, Alexandra
    Cerezo, Julieta
    Alejandra Morales, Maria
    Victoria Miranda, Maria
    Rodriguez Talou, Julian
    PROTEIN EXPRESSION AND PURIFICATION, 2017, 131 : 76 - 84
  • [38] Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4+ T Cells to the Dengue Virus Envelope Protein Domain III
    Zaneti, Arthur Baruel
    Yamamoto, Marcio Massao
    Sulczewski, Fernando Bandeira
    Almeida, Bianca da Silva
    Santos Souza, Higo Fernando
    Ferreira, Natalia Soares
    Nascimento Fabris Maeda, Denicar Lina
    Sales, Natiely Silva
    Rosa, Daniela Santoro
    de Souza Ferreira, Luis Carlos
    Boscardin, Silvia Beatriz
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [39] A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates
    Hsin-Wei Chen
    Shih-Jen Liu
    Yi-Shiuan Li
    Hsueh-Hung Liu
    Jy-Ping Tsai
    Chen-Yi Chiang
    Mei-Yu Chen
    Chyi-Sing Hwang
    Chin-Cheng Huang
    Hui-Mei Hu
    Han-Hsuan Chung
    Sze-Hsien Wu
    Pele Chong
    Chih-Hsiang Leng
    Chien-Hsiung Pan
    Archives of Virology, 2013, 158 : 1523 - 1531
  • [40] Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues
    Pitcher, Trevor J.
    Sarathy, Vanessa V.
    Matsui, Kiyohiko
    Gromowski, Gregory D.
    Huang, Claire Y-H
    Barrett, Alan D. T.
    JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 288 - 293